Skip to main content
. 2016 May 3;6(5):e795. doi: 10.1038/tp.2016.59

Table 3. Region of interest analyses showing significant treatment effects.

Contrast L/R CS x y z T Z Brain region
Raloxifene > placebo L 86 −44 −48 4 5.80a 4.35 Inferior frontal gyrus
  R 36 34 −14 −24 4.71a 3.79 Hippocampus
                 
Placebo > raloxifene None              

Abbreviations: CS, cluster size; L, left hemisphere; R, right hemisphere; T, t-value; Z, z-value.

a

Small volume family-wise error corrected, P<0.05.

Significant activation differences in the hippocampus and inferior frontal gyrus following raloxifene treatment compared with placebo. Centers of activation clusters are given by Montreal Neurological Institute stereotactic coordinates (x, y, z).

HHS Vulnerability Disclosure